Evaluation of a Diabetes Data Management System
|ClinicalTrials.gov Identifier: NCT00694070|
Recruitment Status : Completed
First Posted : June 10, 2008
Results First Posted : September 23, 2009
Last Update Posted : February 29, 2016
|Condition or disease|
|Study Type :||Observational|
|Actual Enrollment :||51 participants|
|Official Title:||Evaluation of a Diabetes Data Management System In a Clinical Setting|
|Study Start Date :||July 2008|
|Primary Completion Date :||July 2008|
|Study Completion Date :||July 2008|
health care professionals and lay users
h= 8 health care professionals p= 43 lay users
- Number of Participants That Rated 80% of Tasks as Very Simple, Simple, or Neither Simple Nor Difficult (Ease of Use of the Software Program) [ Time Frame: 1-2 hours ]
After completing each task, subjects rated the ease of performing each task on a scale of 1 to 5.
- Very Simple
- Neither simple nor difficult
- Very Difficult Outcome measure was the number of participants that rated 80% of tasks as 1,2, or 3.
- Number of Participants Rated as <= 3 (Success in Using the Program) [ Time Frame: 1-2 hours ]
Subjects were rated by study staff as to their success at performing basic tasks. The rating scale was:
- successful after being referred to user instructions
- success with assistance (similar to a customer call)
- unsuccessful 5 = software problem Outcome measure was the number of participants rated as <= 3.
- Number of Participants That Could Answer at Least 85% of the Comprehension Questions Correctly (Comprehension of the Program Reports) [ Time Frame: 1-2 hours ]Subjects were asked thirty questions throughout the evaluation to test whether they understood the data displays, graphs and features of the software. Outcome measure was the number of participants that could answer at least 85% of the comprehension questions correctly.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00694070
|United States, California|
|Escondido, California, United States, 92026|
|Principal Investigator:||Timothy Bailey, MD||AMCR Institute|